Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dentsply Sirona

15.40
+0.03000.20%
Post-market: 15.400.00000.00%16:39 EDT
Volume:1.68M
Turnover:25.94M
Market Cap:3.07B
PE:-3.41
High:15.59
Open:15.30
Low:15.26
Close:15.37
Loading ...

Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), DENTSPLY SIRONA (XRAY) and Cytokinetics (CYTK)

TIPRANKS
·
03 Mar

DENTSPLY SIRONA (NASDAQ:XRAY) Has Affirmed Its Dividend Of $0.16

Simply Wall St.
·
02 Mar

DENTSPLY SIRONA’s Mixed Earnings Call Insights

TIPRANKS
·
01 Mar

Stock Track | Dentsply Sirona Plummets 5% on Disappointing Earnings, Analyst Downgrades

Stock Track
·
01 Mar

Dentsply Sirona Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
01 Mar

Barrington Adjusts Price Target on DENTSPLY SIRONA to $20 From $24, Keeps Outperform Rating

MT Newswires Live
·
28 Feb

Morgan Stanley Reaffirms Their Buy Rating on DENTSPLY SIRONA (XRAY)

TIPRANKS
·
28 Feb

DENTSPLY SIRONA Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
28 Feb

Dentsply Sirona price target lowered to $19 from $20 at Wells Fargo

TIPRANKS
·
28 Feb

Dentsply Sirona price target lowered to $19 from $20 at BofA

TIPRANKS
·
28 Feb

Dentsply Sirona Is Maintained at Buy by Needham

Dow Jones
·
28 Feb

Hold Rating for DENTSPLY SIRONA Amid Cost-Cutting and Market Challenges

TIPRANKS
·
28 Feb

Dentsply Sirona Inc (XRAY) Q4 2024 Earnings Call Highlights: Navigating Challenges and ...

GuruFocus.com
·
28 Feb

Dentsply Sirona Faces Challenges with 2024 Earnings

TIPRANKS
·
28 Feb

Q4 2024 DENTSPLY SIRONA Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Analysts’ Top Healthcare Picks: Heron Therapeutics (HRTX), DENTSPLY SIRONA (XRAY)

TIPRANKS
·
28 Feb

Dentsply Sirona Q4: Earnings Miss, 10% Sales Drop, Soft 2025 Outlook And More

Benzinga
·
27 Feb

BUZZ- Dentsply Sirona falls on downbeat 2025 sales forecast

Reuters
·
27 Feb

XRAY Q4 Earnings & Revenues Miss Estimates, Gross Margin Down

Zacks
·
27 Feb

Stock Track | Dentsply Sirona Plunges Over 5% on Disappointing Earnings and Weak 2025 Guidance

Stock Track
·
27 Feb